To gain an understanding of the role of Medical Communications, Publications and Training within the Global Medical Multiple Sclerosis and Neuroscience team, through broad hands-on experiences, dedicated mentorship and longitudinal core responsibilities that will prepare the Fellow for a career in the pharmaceutical industry.
Develop skills in both data generation and data dissemination that facilitate medical communications and publications providing scientific excellence for the ultimate benefit of patients.
Contribute to the execution of the strategic medical communication tactics including scientific platform, interactive digital materials (brochures, animation videos, publication digital enhancements, internal/external websites and platforms, etc), and training resources.
Execute strategic publication plans in accordance with policies and International Committee of Medical Journal Editors (ICMJE) guidelines, collaborating with key internal and external stakeholders and agency partners.
Become an integral member of congress planning teams to develop materials and publications supporting key neurology and multiple sclerosis medical congresses such as the American Academy of Neurology (AAN), Consortium of Multiple Sclerosis Centers (CMSC), European Academy of Neurology (EAN), Peripheral Nerve Society (PNS), and European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS).
Participate in new hire training curriculum to build verbalization skills and scientific acumen necessary for direct scientific exchange with healthcare providers (Sanofi MSL certification opportunity available).
To be considered for an interview, please complete a fellowship application on the MCPHS SMApply application portal. Visit https://mcphs.smapply.io/
Please DO NOT request an interview within PPS. Our recruitment teams will contact qualified candidates via email to schedule interviews.
The MCPHS application portal will open up on October 3, 2022. Applicants must upload the following application materials to the online portal by November 11, 2022:
Letter of intent
Unofficial college transcript
Contact information for three references. References will receive an electronic recommendation form to complete separately.
Incomplete applications WILL NOT be reviewed. Interviews CANNOT be scheduled until these materials have been submitted. Please keep in mind that this is a competitive process and applicants are encouraged to complete their applications as soon as possible.
Three recommendation evaluation forms must be submitted no later than December 1, 2022, via the online portal. This is NOT a letter of recommendation but an online form that the reference will need to complete.
Rolling Application Review & Interviews
All submitted applications will be reviewed on a rolling basis. Interviews will also be offered on a rolling basis and opportunities are limited. Priority will be given to those applicants who apply early, well in advance of the deadline.
Rolling interviews will begin mid-October with pre-screens and a mixture of interview rounds, and will conclude in December at the end of the ASHP Midyear Clinical Meeting. Candidates will be notified if selected for an interview.
ASHP Midyear & Onsite Interviews
The fellowship program will be conducting in-person interviews at the ASHP Midyear Clinical Meeting in Las Vegas. Applicants are strongly encouraged to attend. Candidates attending in-person will not be able to interview without registering for both ASHP and PPS. Please refer to the ASHP & PPS website for registration details.
Top candidates may be invited for interviews at the sponsoring company’s location pending COVID – 19 restrictions.
Recognizing that the choice of a Post-Doctoral Industry Fellowship is an important decision, MCPHS in conjunction with the Academic Industry Fellowship Alliance (AIFA), has agreed to extend offers for Fellowships no earlier than December 7, 2022.
Final candidates will be required to go through additional screening / onboarding as required by MCPHS.
The MCPHS Biopharmaceutical Industry fellows will be selected on a nationally competitive basis. Applicants must have a Doctor of Pharmacy degree from an ACPE accredited college of pharmacy at the commencement of the program.
Candidates must have strong written and verbal communication skills and a strong interest in pursuing a career within the biopharmaceutical industry.
All candidates must have authorization to work in the United States throughout the duration of the one or two year fellowship. No visa sponsorship will be provided (i.e., TN, H-1B, STEM OPT, etc.).
Sanofi is an innovative global healthcare company, driven by one purpose: we chase the miracles of science to improve people’s lives. Sanofi’s global specialty care business unit focuses on rare diseases, rare blood disorders, neurology, immunology, and oncology. Its approach is shaped by a long history of developing highly specialized treatments and forging close relationships with physician and patient communities. Our cutting-edge science and manufacturing, fueled by data and digital technologies, have the potential to transform the practice of medicine for millions of people around the world.